510(k) Report

510(k) · Cleared

Cleared

Tytron C-500IR Clinical Infrared Imaging System

K032471510(k) TraditionalCleared Oct 10, 200360-day reviewClass I21 CFR 884.2980

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Titronics Research & Development Co. · LHQ System, Telethermographic (Adjunctive Use)

Cleared on Oct 10, 2003 as substantially equivalent to K020783 (Telesis Technologies, Inc., 2002) after a 60-day review. Its family tree reaches back 1 generation to 2002.

Decided
Oct 10, 2003
Review
60 days
Class
Class I
Product code
LHQ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K020783 (2002). No later device cites it as a predicate yet.

  1. Root · 1 generation backK020783 Telesis Digital Infrared Thermal Image System, Spectrum 9000MBTelesis Technologies, Inc. · 2002
  2. This deviceK032471 Tytron C-500IR Clinical Infrared Imaging SystemTitronics Research & Development Co. · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K020783Telesis Digital Infrared Thermal Image System, Spectrum 9000MBTelesis Technologies, Inc.2002—
0 (this device)K032471Tytron C-500IR Clinical Infrared Imaging SystemTitronics Research & Development Co.2003—
FIG. 1 — Lineage of K032471, 2002–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LHQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LHQ device

  1. #1 K253911 Derma-2score 12.0 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K020783Telesis Digital Infrared Thermal Image System, Spectrum 9000MBTelesis Technologies, Inc.2002—

Also cleared against K020783: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K020783.

How does its category compare?

All LHQ devices

LHQ System, Telethermographic (Adjunctive Use): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LHQ

1in 2023

2008: 12011: 12012: 12015: 12016: 12017: 22019: 12021: 22022: 22023: 12026 (partial year): 1
2007high 2 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LHQ

Too few LHQ 510(k)s in any year since 2007 to give a median.

Recalls per year · LHQ

No recall names LHQ since 2007.

Adverse event reports per year · LHQ

1in 2025

2013: 12019: 22020: 12021: 12025: 1
2007high 2 (2019) · low 0 (2007)2025

MAUDE reports naming product code LHQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20090—00
20100—00
20111—00
20121—00
20130—01
20140—00
20151—00
20161—00
20172—00
20180—00
20191—02
20200—01
20212—01
20222—00
20231—00
20240—00
20250—01
20261—0—

What is it indicated for?

The TyTron C-500iR Clinical infrared Imaging System is intended for adjunctive hagnostic screening for the detection of breast cancer and other uses such as: peripheral vascular disease. neuromusculoskeletal disorders, extracranial cerebral and facial vascular chsease, thyroid gland abnornihties, and vaiious other neoplasfc, metabolic, and inflammatory conditions. Use of the TyTron C-SOOIR System is not. intended to be the sole dlapostic procedure for these hseases and conht,ions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032471: Tytron C-500IR Clinical Infrared Imaging System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K032471

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026